![](https://www.win-partners.co.jp/wp/wp-content/uploads/2023/05/TOP_Number_EN_1_202305.jpg)
Japan’s No.1 in cardiovascular sales
We have the largest market share in the products for PCI (percutaneous coronary intervention), minimally invasive treatments for myocardial infarction and angina pectoris in Japan.
*(Source) WIN Partners
![](https://www.win-partners.co.jp/wp/wp-content/uploads/2024/05/TOP_Number_EN_1_202403.jpg)
Financial summary.
WIN-Partners group aims for higher growth, by expanding sales network and customer base as well as expanding treatment areas and products.
NEWSNews Release
2024.06.24 | Progress of initiatives for material issues |
---|---|
2024.06.03 | THE 11TH ANNUAL GENERAL MEETING OF SHAREHOLDERS |
2024.05.22 | Full year presentation slides |
2024.05.14 | Consolidated Financial Results(Fiscal Year Ended March 31, 2024) |
2024.03.28 | Notice Regarding the important personnel change |